Norwich Cancer Research Network
  • About
  • News/Events
  • Our Themes
  • Researchers
  • Funders
  • Case studies
  • Contact
Contact

< Our Themes

Therapies

We are developing new anti-cancer agents and new ways to deliver them, including nanocarriers and personalised therapies.

Researchers

Dr Daniel Holyoake Dr Debashis Biswas Mr Edward Cheong Dr Gaurav Kapur Dr Jennifer Garioch Prof. Marc Montcrieff Dr Richard Tighe Mr Robert Mills Dr Robert Wade Professor Felix Naughton Prof. Kristian Bowles Dr Susanna Alexander Mr James Hernon Mr Adam Stearns Prof. Bill Fraser Prof. Caitlin Notley Claire Devlin Dr Gill Gray Dr Helen Swannie Dr Jenny Nobes Dr Joanna Semlyen Prof. Nicole Horwood Dr Pinelopi Gkogkou Dr Tom Roques Dr Wendy Hardeman Dr Zacharias Tasigiannopolous Dr Maria Jose Marin Mr Simon Pain Dr Simon Rushbrook Dr Sheng Qi Dr Adrian Harnett Prof. Arasu Ganesan Dr Christopher Morris Prof. Mark Searcey Dr Susan Matthews Dr Vicki Sherwood Dr Zoe Waller Prof. Grant Wheeler Prof. Charles Brearley Prof. Maria O’Connell

Case studies related to this theme

    New nanoparticle cancer therapy takes a step closer to clinical trials

    New nanoparticle cancer therapy takes a step closer to clinical trials

    A tumour-promoting protein, (SK1), was identified in prostate and breast cancer cells which reduces the effectiveness of chemotherapy.

    Read more >>

News within this theme

    NCRN Virtual Seminar: Dr Girgis Obaid, Department of Bioengineering, University of Texas at Dallas

    Join us 25th of November 2020 at 12pm for a seminar titled 'Precision nanomedicines for cancer therapy: shedding light on the conundrum of tumor targeting'.

    Read more >>

More themes

    Prevention Diagnostics Therapeutic targets/fundamental mechanisms (Cell targets) Translational Medical Devices and Digital Palliative CareĀ  Health Economics